We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: Agenus (AGEN)

09 Jan 2015 10:54 AM <--
26 Jan 2004 02:40 AM

Return to Agenus (AGEN)
AGEN is an interesting company deserving of some discussion\investment consideration in my opinion.

Worthwhile article on the company and to the workings of wall street (piper Jaffrey suspended coverage at 12/01 because it didn't get the secondary offering business)

AGEN is not discussed much on SI, and when it is it is just as likely to be mentioned on the biotech short thread as it is to be mentioned favorably. But some of the shorts concerns (CFO leaving and Jaffrey coverage suspension) were explained in the above article. Short ratio is rather high at about 20% of the float (12/03).

TA aficionados would probably wait for it to pull back (currently 11.77) or clear resistance at 12.40 to 13. A cross of the 50 day sma over the 200 day sma concurrent with a break of resistance might provide a good entry point.[l,a]dacanyay[pb50!b200!f][vc60][iUc20!Ll14]&pref=G